IL1B rs1143684: Understanding Your Inflammatory Response Gene
The genetic variant rs1143684 is a common single nucleotide polymorphism located within the IL1B gene. It is studied as a potential modifier of the human inflammatory response and its influence on responses to certain anti-TNF therapies.
What each genotype means
Typical inflammatory response profile
This genotype represents the most common configuration for this variant in many populations. Research suggests this variant may act as a modifier of inflammatory responses, potentially influencing how an individual responds to certain anti-TNF therapies. Please discuss any medication-related concerns or treatment plans with your clinician or pharmacist.
This is the most common genotype observed across most global populations.
Modified inflammatory response profile
Carrying one copy of the T allele may be associated with variations in how the body regulates inflammatory cytokines. Some studies suggest this could influence the efficacy of anti-TNF therapies, though evidence remains limited and may vary by ancestry. Please discuss your treatment options and any medication-related questions with your clinician or pharmacist.
This genotype is found at moderate frequencies in many populations, though exact prevalence varies significantly by ancestry.
Alternative inflammatory response profile
This genotype represents the less common configuration for this variant. It is studied as a potential modifier of the inflammatory response, which may impact how some individuals respond to anti-TNF medications. Because the evidence is limited, please consult with your clinician or pharmacist regarding any specific medication dosing or therapy adjustments.
This genotype is the least common of the three, with frequencies varying widely depending on the specific ancestral background of the population.
What is rs1143684 and Where Does It Sit?
The genetic variant rs1143684 is a single nucleotide polymorphism (SNP) located within the IL1B gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. Specifically, this variant involves a substitution where the nucleotide cytosine (C) is replaced by thymine (T). This SNP is situated in a region of the genome that provides instructions for the interleukin-1 beta protein, a key player in the human immune system. Because this location is known to be polymorphic—meaning it varies frequently among people—researchers track it to understand how slight differences in DNA sequence may influence biological processes. While rs1143684 is physically located within the IL1B gene, it is part of a larger, complex genetic landscape that regulates how our bodies initiate and control inflammation in response to injury, infection, or chronic disease states.
The Role of the IL1B Gene
The IL1B gene provides the blueprint for producing interleukin-1 beta, a potent cytokine protein. Cytokines are essentially chemical messengers that coordinate the immune system’s response to threats. When the body detects a pathogen or tissue damage, IL1B is activated to trigger inflammation, which helps clear the threat and begin the healing process. However, inflammation must be tightly regulated; if it is too weak, the body cannot fight infections, but if it is too strong or persistent, it can damage healthy tissue and contribute to chronic inflammatory conditions. By acting as an early-warning signal, the IL-1 beta protein recruits other immune cells to the site of irritation. Because this gene sits at the top of a signaling cascade, variations within its sequence, such as rs1143684, are of significant interest to scientists studying why some individuals experience stronger inflammatory responses than others.
Research Associations and Evidence Strength
The association between rs1143684 and health outcomes is considered limited in the broader scientific community. Much of the research has focused on the variant's potential role as a modifier of the inflammatory response, specifically in the context of autoimmune conditions and responses to anti-TNF (tumor necrosis factor) therapies. Some studies have suggested that individuals carrying certain alleles of this SNP might exhibit different levels of cytokine production, which could theoretically alter how they respond to treatments that dampen the immune system. However, findings across different clinical trials have been inconsistent. In many cases, an association observed in one study group could not be replicated in another, often due to differences in ancestry, disease severity, or other genetic and environmental factors. Consequently, while rs1143684 is a well-cataloged marker, it is not currently used as a definitive predictor for clinical decision-making.
What You Can and Cannot Do With This Information
It is important to remember that genetic information is only one piece of a very large health puzzle. You cannot use this information to diagnose yourself with an inflammatory disorder or to predict exactly how you will respond to a specific medication. Genetic associations, particularly those with limited evidence like rs1143684, do not equate to a medical outcome. If you are curious about how your genetics might influence your health or a potential treatment plan, the best course of action is to speak with your healthcare provider or a licensed genetic counselor. They can help you interpret these findings in the context of your personal health history, current symptoms, and clinical data. Never change your medication dosage or discontinue a treatment based on genetic test results without consulting your clinician or pharmacist, as they are equipped to make decisions based on the full clinical picture.
How common is this variant?
The rs1143684 variant is considered common across diverse human populations, meaning that both the C and T alleles are frequently observed in individuals worldwide.
Frequently asked questions
Is rs1143684 a cause of autoimmune disease?
No, rs1143684 is not considered a causative gene for autoimmune disease. It is a common genetic variant that may subtly modify inflammatory responses, but it does not determine the development of disease on its own.
Can I use this SNP to predict my response to anti-TNF medication?
Current evidence is limited and inconsistent regarding the use of this SNP for predicting drug response. Clinical decisions regarding medication should always be made by your doctor based on clinical symptoms and standard diagnostic tests, not just genetic markers.
Where can I find more information about my specific genotype?
You can look up your rsID in databases like the GWAS Catalog or PubMed to see the latest published studies. However, always discuss these findings with a qualified medical professional who can explain what the research actually means for you.
Why do different sources say different things about this SNP?
Genetic research often yields mixed results because studies are conducted on different populations with varying environmental factors and disease types. When evidence is labeled limited, it means the scientific community has not yet reached a consensus on the variant's clinical impact.
Sources & further reading
Educational information only, last refreshed 10/3/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1143684?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL1B
This variant is associated with altered cytokine production and susceptibility to inflammatory conditions.
This polymorphism in the interleukin-1 beta gene has been studied for its role in the pharmacogenomics of apremilast response in patients with psoriasis.
Promoter single nucleotide polymorphism influencing baseline inducible interleukin-1 beta transcriptional activity and inflammatory response phenotypes.
Interleukin-1 beta variant that modulates the anti-inflammatory efficacy of dietary omega-3 polyunsaturated fatty acids and systemic inflammatory markers.
Promoter variant (c.-511C>T / c.-598C>T depending on transcript) in the IL1B gene extensively studied for regulatory influence on interleukin-1 beta expression and chronic inflammatory states.
Promoter regulatory single-nucleotide variant in interleukin-1 beta associated with altered inflammatory cytokine secretion and chronic inflammation predisposition.